Johnson & Johnson vs Ralph Lauren Corp — how do they compare? Johnson & Johnson trades at $261.11 (market cap $626.09B), while Ralph Lauren Corp trades at $396.24 (market cap $23.70B). The key difference: Johnson & Johnson is far larger — about 26.4× Ralph Lauren Corp's market cap, and Johnson & Johnson pays the higher dividend (2.06%). Which is the better fit depends on your goals.
| JNJ | RL | |
|---|---|---|
Market Cap | $626.09B | $23.70B |
Volume | 6,156,228 | — |
Sector | Health | Consumer Cyclical |
52-Week High | $267.24 | $414.25 |
52-Week Low | $172.78 | $285.35 |
Enterprise Value | $654.37B | $24.76B |
Dividend Yield | 2.06% | 0.94% |
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
Ralph Lauren (RL) trades at $391.57, down 3.77% today, but maintains a bullish technical trend with strong fundamental performance. The company has beaten earnings estimates for four consecutive quarters, with Q2 2026 EPS of $4.59 exceeding expectations. Revenue growth is robust, reaching $7.08B in 2025, with a net income margin of 11.76%. Analyst sentiment is overwhelmingly positive, with a 66% buy rating and a consensus price target of $456.50, suggesting significant upside potential from current levels.
The outlook for RL is favorable, driven by consistent earnings beats, margin expansion, and strong brand momentum. Key opportunities include global demand growth and dividend sustainability. Risks involve consumer spending volatility and competitive pressures in the retail sector. The stock's current valuation metrics, such as a P/E of 25.06, are justified by its profitability and growth trajectory, supporting a constructive view for investors.
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →Founded by designer Ralph Lauren in 1967, Ralph Lauren Corp. designs, markets, and distributes lifestyle products in North America, Europe, and Asia. Its products include apparel, footwear, eyewear, jewelry, leather goods, home products, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, Lauren Ralph Lauren, and Double RL. Distribution channels for Ralph Lauren include wholesale (including department stores and specialty stores), retail (including company-owned retail stores and e-commerce), and licensing.
Read more on RL →